Know more

Our use of cookies

Cookies are a set of data stored on a user’s device when the user browses a web site. The data is in a file containing an ID number, the name of the server which deposited it and, in some cases, an expiry date. We use cookies to record information about your visit, language of preference, and other parameters on the site in order to optimise your next visit and make the site even more useful to you.

To improve your experience, we use cookies to store certain browsing information and provide secure navigation, and to collect statistics with a view to improve the site’s features. For a complete list of the cookies we use, download “Ghostery”, a free plug-in for browsers which can detect, and, in some cases, block cookies.

Ghostery is available here for free: https://www.ghostery.com/fr/products/

You can also visit the CNIL web site for instructions on how to configure your browser to manage cookie storage on your device.

In the case of third-party advertising cookies, you can also visit the following site: http://www.youronlinechoices.com/fr/controler-ses-cookies/, offered by digital advertising professionals within the European Digital Advertising Alliance (EDAA). From the site, you can deny or accept the cookies used by advertising professionals who are members.

It is also possible to block certain third-party cookies directly via publishers:

Cookie type

Means of blocking

Analytical and performance cookies

Realytics
Google Analytics
Spoteffects
Optimizely

Targeted advertising cookies

DoubleClick
Mediarithmics

The following types of cookies may be used on our websites:

Mandatory cookies

Functional cookies

Social media and advertising cookies

These cookies are needed to ensure the proper functioning of the site and cannot be disabled. They help ensure a secure connection and the basic availability of our website.

These cookies allow us to analyse site use in order to measure and optimise performance. They allow us to store your sign-in information and display the different components of our website in a more coherent way.

These cookies are used by advertising agencies such as Google and by social media sites such as LinkedIn and Facebook. Among other things, they allow pages to be shared on social media, the posting of comments, and the publication (on our site or elsewhere) of ads that reflect your centres of interest.

Our EZPublish content management system (CMS) uses CAS and PHP session cookies and the New Relic cookie for monitoring purposes (IP, response times).

These cookies are deleted at the end of the browsing session (when you log off or close your browser window)

Our EZPublish content management system (CMS) uses the XiTi cookie to measure traffic. Our service provider is AT Internet. This company stores data (IPs, date and time of access, length of the visit and pages viewed) for six months.

Our EZPublish content management system (CMS) does not use this type of cookie.

For more information about the cookies we use, contact INRA’s Data Protection Officer by email at cil-dpo@inra.fr or by post at:

INRA
24, chemin de Borde Rouge –Auzeville – CS52627
31326 Castanet Tolosan CEDEX - France

Dernière mise à jour : Mai 2018

Menu Logo Principal Lyon 1 EPHE

Home page

Our publications

Gomes, M., F. Archer, N. Girard, B. Gineys, C. Dolmazon, A. Bobet Erny, J. F. Mornex, and C. Leroux. Blocked expression of key genes of the angiogenic pathway in JSRV-induced pulmonary adenocarcinomas. Vet Res 2017 48:76.

Vituret C, Gallay K, Confort MP, Ftaich N, Matei CI, Archer F, Ronfort C, Mornex JF, Chanson M, DiPietro A, Boulanger P, Hong SS. Transfer of the cystic fibrosis transmembrane conductance regulator to human cystic fibrosis cells mediated by extracellular vesicles. Hum Gene Ther 2016 27(2):166-83.

Chebib, N., C. Khouatra, R. Lazor, F. Archer, C. Leroux, D. Gamondes, F. Thivolet-Bejui, J. F. Cordier, and V. Cottin. Pulmonary lymphangioleiomyomatosis: From pathogenesis to management. Rev Mal Respir 2016. 33:718-734.

Monot M, Erny A, Gineys B, Desloire S, Dolmazon C, Aublin-Gex A, Lotteau V, Leroux C*, Archer F* (*equally contributed). Early steps of Jaagsiekte Sheep Retrovirus-mediated cell transformation involve the interaction between Env and the RALBP1 cellular protein. J Virol 2015 89(16):8462-73

Monot, M., F. Archer, M. Gomes, J. F. Mornex, and C. Leroux. Advances in the study of transmissible respiratory tumours in small ruminants. Vet Microbiol 2015. 181:170-177.

Archer F, Abi-Rizk A, Desloire S, Dolmazon C, Gineys B, Guiguen F, Cottin V, Mornex J-F and Leroux C Lung progenitors from lambs can differentiate into specialized alveolar or bronchiolar epithelial cells BMC Vet Res 2013 9:224.

Bolfa P, Nolf M, Cadore J-L, Catoi C, Archer F, Dolmazon C, Mornex J-F, Leroux C. Interstitial lung disease associated with EIAV infection in horses. Vet Res 2013 44:113.

Viginier B, Dolmazon C, Lantier I, Lantier F, Archer F, Leroux C, Terzian C. Copy number variation and differential expression of a protective endogenous retrovirus in sheep. PLoS One. 2012 7(7) e41965

Archer, F., J. F. Mornex, and C. Leroux. Interplay between JSRV, an oncogenic retrovirus, and the pulmonary epithelium. Current Immunology Reviews 2012. 7:209-215.

Cottin, V., F. Archer, C. Leroux, J. F. Mornex, and J. F. Cordier. Milestones in lymphangioleiomyomatosis research. Eur Respir Rev 2011. 20:3-6.

Cottin V, Archer F,  Khouatra C, Lazor R, Cordier JF. Lymphangioleiomyomatosis. Presse Med. 2010 Jan;39(1):116-25.

Varela M, Golder M, Archer F, de las Heras M, Leroux C, Palmarini M.A Large animal model to evaluate the effects of Hsp90 inhibitors for the treatment of lung adenocarcinoma. Virology. 2008 371(1):206-15.

Leroux, C., N. Girard, V. Cottin, T. Greenland, J. F. Mornex, and F. Archer. Jaagsiekte Sheep Retrovirus (JSRV): from virus to lung cancer in sheep. Vet Res 2007 38:211-228.

Archer F, Jacquier E, Lyon M, Chastang J, Cottin V, Mornex JF, Leroux C. Alveolar type II cells isolated from pulmonary adenocarcinoma: a model for JSRV expression in vitro Am J Respir Cell Mol Biol. 2007 36(5):534-40.

Suau, F., N. Girard, F. Archer, V. Cottin, S. Croze, J. F. Mornex, and C. Leroux. 2006. JSRV (jaagsiekte sheep retrovirus) et cancer du poumon associé chez le mouton. Virologie 10:287-299

Suau F, Cottin V, Archer F, Croze S, Chastang J, Cordier G, Thivolet-Béjui F, Mornex JF, Leroux C. Telomerase activation in a model of lung adenocarcinoma Eur Respir J. 2006 27(6):1175-82.

Blanc-Brude OP, Archer F, Leoni P, Derian C, Bolsover S, Laurent GJ, Chambers RC. Factor Xa stimulates fibroblast procollagen production, proliferation, and calcium signaling via PAR1 activation Exp Cell Res. 2005 304(1):16-27.

Fevrier B, Vilette D, Archer F, Loew D, Faigle W, Vidal M, Laude H, Raposo G. Cells release prions in association with exosomes. Proc Natl Acad Sci USA. 2004 101(26):9683-8.

Beringue V, Vilette D, Mallinson G, Archer F, Kaisar M, Tayebi M, Jackson GS, Clarke AR, Laude H, Collinge J, Hawke S. PrPSc binding antibodies are potent inhibitors of prion replication in cell lines. J Biol Chem.  2004 279(38):39671-6.

Archer F, Bachelin C, Andreoletti O, Besnard N, Perrot G, Langevin C, Le Dur A, Vilette D, Baron-Van Evercooren A, Vilotte JL, Laude H. Cultured peripheral neuroglial cells are highly permissive to sheep prion infection. J Virol. 2004 78(1):482—90

Laude H, Vilette D, Le Dur A, Archer F, Soulier S, Besnard N, Essalmani R, Vilotte JL New in vivo and ex vivo models for the experimental study of sheep scrapie: development and perspectives. C R Biol.  2002 Jan; 325(1):49-57.

Vilette D, Andreoletti O, Archer F, Madelaine MF, Vilotte JL, Lehmann S, Laude H. Ex vivo propagation of infectious sheep scrapie agent in heterologous epithelial cells expressing ovine prion protein. Proc Natl Acad Sci USA. 2001 Mar 27;98(7):4055-9. 

Finn JT, Weil M, Archer F, Siman R, Srinivasan A, Raff MC. Evidence that Wallerian degeneration and localized axon degeneration induced by local neurotrophin deprivation do not involve caspases. J Neurosci. 2000 Feb 15;20(4):1333-41

Archer FR, Doherty P, Collins D, Bolsover SR. CAMs and FGF cause a local submembrane calcium signal promoting axon outgrowth without a rise in bulk calcium concentration. Eur J Neurosci. 1999 Oct;11(10):3565-73.

Bolsover S, Ashworth R, Archer F. Activator of calcium influx proves a slippery customer. J Physiol. 1999 May 15;517 ( Pt 1):121-34.